Drug
Eq001
Eq001: highest development phase Phase 3, developed by Biocon. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| EQ001 NCT04605926 | Phase 3 | Coronavirus |
| EQ001 NCT03763318 | Phase 1/2 | Acute-graft-versus-host Disease |
| EQ001 NCT04007198 | Phase 1 | Asthma |
Latest
No recent events.
Follow Eq001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.